Notably, iCAFs may induce CD8 + T cells apoptosis and impair their anti-tumor functions by interacting with CD8 + T cells PTPRC receptors via Galectin-1 (LGALS1) [34, 35] (Fig. 4f and S15; Table S9). This evidence concerns the gene CD8A and neoplasm.